< Back to search trials

A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-Negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)

  • Clinicaltrials.gov #: NCT03701334
  • Acronym: NATALEE
  • Tumor Type: Breast
  • Tumor Subtype: ER +ve
  • Tumor Stage: N/A
  • Type of Treatment: